Q&A: COVID-19 study to phenotype degree of multiorgan injury in recovering patients

During this COVID-19 pandemic, many scientists have turned their efforts to find either a treatment or vaccine for the infection or trying to better understand the infection.In a recent release, Perspectum announced they launched the CoverScan study, the first study that will determine how COVID-19 impacts the health of multiple organs and to identify at-risk features in patients recovering from this virus. Their objective is to determine the degree of lung, heart, kidney, liver, pancreas and spleen injury in patients who are recovering from COVID-19. They will be using MRIs, blood tests,Read More

Share on facebook
Share on twitter
Share on linkedin